Literature DB >> 10523020

Human leukocyte antigen-A24 and -DQA1*0301 in Japanese insulin-dependent diabetes mellitus: independent contributions to susceptibility to the disease and additive contributions to acceleration of beta-cell destruction.

K Nakanishi1, T Kobayashi, T Murase, T Naruse, Y Nose, H Inoko.   

Abstract

The aim of this study is to identify insulin-dependent diabetes mellitus (IDDM)-susceptible HLA antigens in IDDM patients who do not have established risk allele, HLA-DQA1*0301, and analyze relationship of these HLA antigens and the degree of beta-cell destruction. In 139 Japanese IDDM patients and 158 normal controls, HLA-A, -C, -B, -DR and -DQ antigens were typed. Serum C-peptide immunoreactivity response (deltaCPR) to a 100-g oral glucose load < or = 0.033 nmol/l was regarded as complete beta-cell destruction. All 14 patients without HLA-DQA1*0301 had HLA-A24, whereas only 35 of 58 (60.3%) normal controls without HLA-DQA1*0301 and only 72 of 125 (57.6%) IDDM patients with HLA-DQA1*0301 had this antigen (Pc = 0.0256 and Pc = 0.0080, respectively). DeltaCPR in IDDM patients with both HLA-DQA1*0301 and HLA-A24 (0.097 +/- 0.163 nmol/L, mean +/- SD, n = 65) were lower than in IDDM patients with HLA-DQA1*0301 only (0.219 +/- 0.237 nmol/L, n = 45, P < 0.0001) and in IDDM patients with HLA-A24 only (0.187 +/- 0.198 nmol/L, n = 14, P = 0.0395). These results indicate that both HLA-DQA1*0301 and HLA-A24 contribute susceptibility to IDDM independently and accelerate beta-cell destruction in an additive manner.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523020     DOI: 10.1210/jcem.84.10.6045

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

Review 1.  Effector lymphocytes in islet cell autoimmunity.

Authors:  Pere Santamaria
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

2.  Beyond HLA-A*0201: new HLA-transgenic nonobese diabetic mouse models of type 1 diabetes identify the insulin C-peptide as a rich source of CD8+ T cell epitopes.

Authors:  Zoltan Antal; Jason C Baker; Carla Smith; Irene Jarchum; Jeffrey Babad; Gayatri Mukherjee; Yang Yang; John Sidney; Alessandro Sette; Pere Santamaria; Teresa P DiLorenzo
Journal:  J Immunol       Date:  2012-04-25       Impact factor: 5.422

Review 3.  Genetics of the HLA region in the prediction of type 1 diabetes.

Authors:  Janelle A Noble; Ana M Valdes
Journal:  Curr Diab Rep       Date:  2011-12       Impact factor: 4.810

4.  Human leukocyte antigen class I B and C loci contribute to Type 1 Diabetes (T1D) susceptibility and age at T1D onset.

Authors:  Ana M Valdes; Henry A Erlich; Janelle A Noble
Journal:  Hum Immunol       Date:  2005-03       Impact factor: 2.850

5.  The HLA class I A locus affects susceptibility to type 1 diabetes.

Authors:  Janelle A Noble; Ana M Valdes; Teodorica L Bugawan; Raymond J Apple; Glenys Thomson; Henry A Erlich
Journal:  Hum Immunol       Date:  2002-08       Impact factor: 2.850

6.  In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A*24 and HLA-B*18, but not HLA-B*39, are predictors of impending diabetes with distinct HLA-DQ interactions.

Authors:  E Mbunwe; B J Van der Auwera; I Weets; P Van Crombrugge; L Crenier; M Coeckelberghs; N Seret; K Decochez; E Vandemeulebroucke; P Gillard; B Keymeulen; C van Schravendijk; J M Wenzlau; J C Hutton; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  2013-05-28       Impact factor: 10.122

7.  Identification of novel IGRP epitopes targeted in type 1 diabetes patients.

Authors:  Irene Jarchum; Lynn Nichol; Massimo Trucco; Pere Santamaria; Teresa P DiLorenzo
Journal:  Clin Immunol       Date:  2008-03-20       Impact factor: 3.969

8.  Predominant occupation of the class I MHC molecule H-2Kwm7 with a single self-peptide suggests a mechanism for its diabetes-protective effect.

Authors:  Daniel R Brims; Jie Qian; Irene Jarchum; Leann Mikesh; Edith Palmieri; Udupi A Ramagopal; Vladimir N Malashkevich; Rodolfo J Chaparro; Torben Lund; Masakazu Hattori; Jeffrey Shabanowitz; Donald F Hunt; Stanley G Nathenson; Steven C Almo; Teresa P Dilorenzo
Journal:  Int Immunol       Date:  2010-01-21       Impact factor: 4.823

9.  Clinical and genetic characteristics of patients with type 1 diabetes associated with interferon therapy.

Authors:  Koji Nakanishi; Satoshi Saitoh
Journal:  Diabetes Care       Date:  2011-02       Impact factor: 19.112

10.  Humoral responses to islet antigen-2 and zinc transporter 8 are attenuated in patients carrying HLA-A*24 alleles at the onset of type 1 diabetes.

Authors:  Anna E Long; Kathleen M Gillespie; Rachel J Aitken; Julia C Goode; Polly J Bingley; Alistair J K Williams
Journal:  Diabetes       Date:  2013-02-08       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.